Skip to main content
Publications
Lebwohl M, Blauvelt A, Augustin M, Zhao Y, Gilloteau I, Herrera V, Milutinovic M, You R, Mordin M , McLeod L , Strober B. Secukinumab skin clearance is associated with greater improvements in patient-reported pain, itching, and scaling . Poster presented at the 2016 AAD Summer Meeting; July 2016. Boston, MA.
Vardavas CI, Hohmann C, Patelarou E, Martinez D , Henderson AJ, Granell R, Sunyer J, Torrent M, Fantini MP, Gori D, Annesi-Maesano I, Slama R, Duijts L, de Jongste JC, Aurrekoetxea JJ, Basterrechea M, Morales E, Ballester F, Murcia M, Thijs C, Mommers M, Kuehni CE, Gaillard EA, Tischer C, Heinrich J, Pizzi C, Zugna D, Gehring U, Wijga A, Chatzi L, Vassilaki M, Bergstrom A, Eller E, Lau S, Keil T, Nieuwenhuijsen M, Kogevinas M. The independent role of prenatal and postnatal exposure to active and passive smoking on the development of early wheeze in children . Eur Respir J. 2016 Jul;48(1):115-24. doi: 10.1183/13993003.01016-2015
Maurel J, Lopez-Pousa A, Calabuig S, Bague S, Del Muro XG, Sanjuan X, Rubio-Casadevall J, Cuatrecasas M, Martinez-Trufero J, Horndler C, Fra J, Valverde C, Redondo A, Poveda A, Sevilla I, Lainez N, Rubini M, Garcia-Albeniz X , Martin-Broto J, de Alava E. Phosphorylated-insulin growth factor I receptor (p-IGF1R) and metalloproteinase-3 (MMP3) expression in advanced gastrointestinal stromal tumors (GIST). A GEIS 19 study . Clin Sarcoma Res. 2016 Jun 29;6:10. doi: 10.1186/s13569-016-0050-6
Garcia-Albeniz X . CIBERESP workshop . Presented at the 2016 Centro de Investigación Biomedica en Red, Epidemiology and Public Health Section Meeting; June 29, 2016. Madrid, Spain.
Blonde L, Kitio-Dschassi B, Guerci B, Meyers J , Berria R, Ajmera M, Nikonova E, Davis K , Bertolini M, Raccah D. A real-world comparison of longitudinal HbA1c and health care costs in patients receiving two oral antidiabetic therapies, GLP-1RAs, or basal insulin . Presented at the 76th American Diabetes Association (ADA) Scientifc Sessions; June 13, 2016. New Orleans, LA.
Maurer M, Houghton K , Stull D, McBride D, Janssens N, Heinrichs N, Antonova E, Balp MM, Khalil S. Characterization of responders to omalizumab: exploratory analysis of phase III data from patients with chronic spontaneous urticaria . Poster presented at the European Academy of Allergy and Clinical Immunology Congress; June 13, 2016. Vienna, Austria.
Ensor CR, Harrigan (Zhang) K , Venkataramanan R, Morrell MR, Moore CA, Hayanga JA, Crespo MM, D’Cunha J, Zeevi A, McDyer JF. Increasing tacrolimus time-in-therapeutic range is associated with less cellular rejection in lung transplant recipients . Presented at the 2016 American Transplant Congress; June 12, 2016. Boston, MA.
Blonde L, Kitio-Dschassi B, Guerci B, Meyers J , Berria R, Ajmera M, Nikonova E, Davis K , Bertolini M, Raccah D. A real-world comparison of outcomes in patients receiving two oral antidiabetic therapies, GLP-1RAs, or basal insulin: an analysis of electronic medical record data . Poster presented at the 76th American Diabetes Association (ADA) Scientifc Sessions; June 12, 2016. New Orleans, LA.
Alcubierre N, Navarrete-Muñoz EM, Rubinat E, Falguera M, Valls J, Traveset A, Vilanova MB, Marsal JR , Hernandez M, Granado-Casas M, Martinez-Gonzalez D, Jurjo C, Franch-Nadal J, Vioque J, Mauricio D. Association of low oleic intake acid with diabetic retinopathy in type 2 diabetic patients: a case-control study . Nutr Metab (Lond). 2016 Jun 4;13(40). doi: 10.1186/s12986-016-0099-5
Abdul-Jawad Altisent O, Ferreira-Gonzalez I, Marsal JR , Ribera A, Auger C, Ortega G, Cascant P, Urena M, Del Blanco BG, Serra V, Sureda C, Igual A, Rovira A, González-Alujas MT, Gonzalez A, Puri R, Cuellar H, Tornos P, Rodes-Cabau J, Garcia-Dorado D. Neurological damage after transcatheter aortic valve implantation compared with surgical aortic valve replacement in intermediate risk patients . Clin Res Cardiol. 2016 Jun;105(6):508-17. doi: 10.1007/s00392-015-0946-9
Strober B, Blauvelt A, Zhao Y, Milutinovic M, Mollon P, You R, Sherif B , Williams N, Fox T, Augustin M, Lebwohl M. Secukinumab treatment provides more effective relief from patient-reported psoriasis-related pain, itching, and scaling than ustekinumab . Poster presented at the 2016 SDPA Annual Summer Dermatology Conference; June 2016. Austin, TX. Previously presented at the 24th European Academy of Dermatology and Venereology Congress.
Strober B, Blauvelt A, Zhao Y, Milutinovic M, Mollon P, You R, Sherif B , Williams N, Fox T, Augustin M, Lebwohl M. Secukinumab treatment provides more effective relief from patient-reported psoriasis-related pain, itching, and scaling than ustekinumab . Poster presented at the 4th Annual Maui Derm NP+PA Summer Meeting; June 2016. Colorado Springs, CO. Previously presented at the 24th European Academy of Dermatology and Venereology Congress.
Blauvelt A, Korman N, Mollon P, Zhao Y, Milutinovic M, You R, Sherif B , Williams N, Fox T, Augustin M. Secukinumab treatment provides faster and more effective relief from patient-reported quality-of- life impact than ustekinumab in subjects with moderate to severe plaque psoriasis . Poster presented at the SDPA Annual Summer Dermatology Conference 2016; June 2016. Austin, TX. Previously presented at the 24th European Academy of Dermatology and Venereology Congress.
Blauvelt A, Korman N, Mollon P, Zhao Y, Milutinovic M, You R, Sherif B , Williams N, Fox T, Augustin M. Secukinumab treatment provides faster and more effective relief from patient-reported quality of life impact than ustekinumab in subjects with moderate to severe plaque psoriasis . Poster presented at the 4th Annual Maui Derm NP+PA Summer Meeting; June 2016. Colorado Springs, CO. Previously presented at the 24th European Academy of Dermatology and Venereology Congress.